Annual Total Liabilities
$635.02 M
-$37.16 M-5.53%
30 June 2024
Summary:
Bio-Techne annual total liabilities is currently $635.02 million, with the most recent change of -$37.16 million (-5.53%) on 30 June 2024. During the last 3 years, it has fallen by -$56.71 million (-8.20%). TECH annual total liabilities is now -11.66% below its all-time high of $718.82 million, reached on 30 June 2019.TECH Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$597.37 M
-$37.65 M-5.93%
30 September 2024
Summary:
Bio-Techne quarterly total liabilities is currently $597.37 million, with the most recent change of -$37.65 million (-5.93%) on 30 September 2024. Over the past year, it has dropped by -$160.25 million (-21.15%). TECH quarterly total liabilities is now -22.14% below its all-time high of $767.19 million, reached on 31 December 2023.TECH Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TECH Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.5% | -21.1% |
| 3 y3 years | -8.2% | -4.2% |
| 5 y5 years | -11.7% | -20.4% |
TECH Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -8.2% | +6.9% | -22.1% | +11.4% |
| 5 y | 5 years | -11.7% | +6.9% | -22.1% | +11.4% |
| alltime | all time | -11.7% | >+9999.0% | -22.1% | >+9999.0% |
Bio-Techne Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $597.37 M(-5.9%) |
| June 2024 | $635.02 M(-5.5%) | $635.02 M(-10.2%) |
| Mar 2024 | - | $706.79 M(-7.9%) |
| Dec 2023 | - | $767.19 M(+1.3%) |
| Sept 2023 | - | $757.61 M(+12.7%) |
| June 2023 | $672.18 M(+13.2%) | $672.18 M(-5.3%) |
| Mar 2023 | - | $710.01 M(+32.4%) |
| Dec 2022 | - | $536.29 M(-10.6%) |
| Sept 2022 | - | $599.57 M(+1.0%) |
| June 2022 | $593.79 M(-14.2%) | $593.79 M(+1.2%) |
| Mar 2022 | - | $586.57 M(-2.6%) |
| Dec 2021 | - | $602.32 M(-3.4%) |
| Sept 2021 | - | $623.23 M(-9.9%) |
| June 2021 | $691.72 M(+7.0%) | $691.72 M(+28.9%) |
| Mar 2021 | - | $536.70 M(-0.1%) |
| Dec 2020 | - | $537.01 M(-12.5%) |
| Sept 2020 | - | $613.81 M(-5.0%) |
| June 2020 | $646.40 M(-10.1%) | $646.40 M(-8.7%) |
| Mar 2020 | - | $707.75 M(+4.8%) |
| Dec 2019 | - | $675.07 M(-10.1%) |
| Sept 2019 | - | $750.80 M(+4.4%) |
| June 2019 | $718.82 M(+39.8%) | $718.82 M(-1.0%) |
| Mar 2019 | - | $726.35 M(-2.9%) |
| Dec 2018 | - | $748.41 M(-1.9%) |
| Sept 2018 | - | $762.73 M(+48.4%) |
| June 2018 | $514.14 M(-15.5%) | $514.14 M(-8.1%) |
| Mar 2018 | - | $559.52 M(+0.3%) |
| Dec 2017 | - | $557.60 M(-1.8%) |
| Sept 2017 | - | $567.57 M(-6.7%) |
| June 2017 | $608.59 M(+143.1%) | $608.59 M(-2.7%) |
| Mar 2017 | - | $625.51 M(-0.6%) |
| Dec 2016 | - | $629.45 M(+1.2%) |
| Sept 2016 | - | $622.08 M(+148.5%) |
| June 2016 | $250.30 M(+15.7%) | $250.30 M(-6.9%) |
| Mar 2016 | - | $268.96 M(-2.9%) |
| Dec 2015 | - | $277.11 M(-4.6%) |
| Sept 2015 | - | $290.37 M(+34.2%) |
| June 2015 | $216.43 M(+221.9%) | $216.43 M(-23.9%) |
| Mar 2015 | - | $284.24 M(-4.7%) |
| Dec 2014 | - | $298.32 M(+32.7%) |
| Sept 2014 | - | $224.85 M(+234.5%) |
| June 2014 | $67.23 M(+65.8%) | $67.23 M(+25.6%) |
| Mar 2014 | - | $53.52 M(-0.2%) |
| Dec 2013 | - | $53.64 M(+2.1%) |
| Sept 2013 | - | $52.53 M(+29.5%) |
| June 2013 | $40.56 M(-9.6%) | $40.56 M(-0.5%) |
| Mar 2013 | - | $40.78 M(+35.9%) |
| Dec 2012 | - | $30.00 M(-6.3%) |
| Sept 2012 | - | $32.02 M(-28.6%) |
| June 2012 | $44.88 M(+42.3%) | $44.88 M(+13.5%) |
| Mar 2012 | - | $39.54 M(+47.8%) |
| Dec 2011 | - | $26.74 M(-31.6%) |
| Sept 2011 | - | $39.08 M(+23.9%) |
| June 2011 | $31.55 M(+85.3%) | $31.55 M(+90.7%) |
| Mar 2011 | - | $16.54 M(+21.0%) |
| Dec 2010 | - | $13.67 M(-14.9%) |
| Sept 2010 | - | $16.06 M(-5.7%) |
| June 2010 | $17.02 M(+9.7%) | $17.02 M(-13.8%) |
| Mar 2010 | - | $19.75 M(+44.3%) |
| Dec 2009 | - | $13.69 M(-14.7%) |
| Sept 2009 | - | $16.04 M(+3.3%) |
| June 2009 | $15.52 M(-23.3%) | $15.52 M(+4.1%) |
| Mar 2009 | - | $14.91 M(+14.4%) |
| Dec 2008 | - | $13.04 M(-32.3%) |
| Sept 2008 | - | $19.26 M(-4.8%) |
| June 2008 | $20.24 M(+17.7%) | $20.24 M(+0.4%) |
| Mar 2008 | - | $20.16 M(+1.5%) |
| Dec 2007 | - | $19.86 M(+34.2%) |
| Sept 2007 | - | $14.80 M(-13.9%) |
| June 2007 | $17.19 M | $17.19 M(+9.4%) |
| Mar 2007 | - | $15.71 M(+29.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | - | $12.16 M(-55.8%) |
| Sept 2006 | - | $27.51 M(-8.8%) |
| June 2006 | $30.16 M(+10.1%) | $30.16 M(+17.1%) |
| Mar 2006 | - | $25.75 M(-3.2%) |
| Dec 2005 | - | $26.61 M(+3.1%) |
| Sept 2005 | - | $25.81 M(-5.8%) |
| June 2005 | $27.39 M(-2.3%) | $27.39 M(-13.7%) |
| Mar 2005 | - | $31.74 M(+16.8%) |
| Dec 2004 | - | $27.17 M(-8.4%) |
| Sept 2004 | - | $29.68 M(+5.9%) |
| June 2004 | $28.04 M(+5.2%) | $28.04 M(-4.0%) |
| Mar 2004 | - | $29.20 M(+5.1%) |
| Dec 2003 | - | $27.79 M(+6.3%) |
| Sept 2003 | - | $26.14 M(-2.0%) |
| June 2003 | $26.66 M(-16.0%) | $26.66 M(-9.9%) |
| Mar 2003 | - | $29.59 M(+5.3%) |
| Dec 2002 | - | $28.11 M(-23.0%) |
| Sept 2002 | - | $36.52 M(+15.1%) |
| June 2002 | $31.73 M(-16.2%) | $31.73 M(-4.0%) |
| Mar 2002 | - | $33.04 M(-1.0%) |
| Dec 2001 | - | $33.38 M(-10.5%) |
| Sept 2001 | - | $37.30 M(-1.5%) |
| June 2001 | $37.86 M(-3.6%) | $37.86 M(+2.5%) |
| Mar 2001 | - | $36.94 M(-5.4%) |
| Dec 2000 | - | $39.04 M(+4.4%) |
| Sept 2000 | - | $37.41 M(-4.7%) |
| June 2000 | $39.26 M(+45.4%) | $39.26 M(-3.2%) |
| Mar 2000 | - | $40.56 M(-6.7%) |
| Dec 1999 | - | $43.50 M(-6.7%) |
| Sept 1999 | - | $46.60 M(+72.6%) |
| June 1999 | $27.00 M(+200.0%) | $27.00 M(+0.7%) |
| Mar 1999 | - | $26.80 M(-3.6%) |
| Dec 1998 | - | $27.80 M(-7.6%) |
| Sept 1998 | - | $30.10 M(+234.4%) |
| June 1998 | $9.00 M(+55.2%) | $9.00 M(+11.1%) |
| Mar 1998 | - | $8.10 M(+17.4%) |
| Dec 1997 | - | $6.90 M(-10.4%) |
| Sept 1997 | - | $7.70 M(+32.8%) |
| June 1997 | $5.80 M(+5.5%) | $5.80 M(+18.4%) |
| Mar 1997 | - | $4.90 M(-14.0%) |
| Dec 1996 | - | $5.70 M(+3.6%) |
| Sept 1996 | - | $5.50 M(0.0%) |
| June 1996 | $5.50 M(+19.6%) | $5.50 M(+12.2%) |
| Mar 1996 | - | $4.90 M(+14.0%) |
| Dec 1995 | - | $4.30 M(-15.7%) |
| Sept 1995 | - | $5.10 M(+10.9%) |
| June 1995 | $4.60 M(+21.1%) | $4.60 M(+17.9%) |
| Mar 1995 | - | $3.90 M(+21.9%) |
| Dec 1994 | - | $3.20 M(-17.9%) |
| Sept 1994 | - | $3.90 M(+2.6%) |
| June 1994 | $3.80 M(+46.2%) | $3.80 M(-9.5%) |
| Mar 1994 | - | $4.20 M(+27.3%) |
| Dec 1993 | - | $3.30 M(-13.2%) |
| Sept 1993 | - | $3.80 M(+46.2%) |
| June 1993 | $2.60 M(-42.2%) | $2.60 M(+4.0%) |
| Mar 1993 | - | $2.50 M(+25.0%) |
| Dec 1992 | - | $2.00 M(-55.6%) |
| Sept 1992 | - | $4.50 M(0.0%) |
| June 1992 | $4.50 M(+36.4%) | $4.50 M(0.0%) |
| Mar 1992 | - | $4.50 M(+7.1%) |
| Dec 1991 | - | $4.20 M(-26.3%) |
| Sept 1991 | - | $5.70 M(+72.7%) |
| June 1991 | $3.30 M(-2.9%) | $3.30 M(-5.7%) |
| Mar 1991 | - | $3.50 M(-2.8%) |
| Dec 1990 | - | $3.60 M(0.0%) |
| Sept 1990 | - | $3.60 M(+5.9%) |
| June 1990 | $3.40 M(+13.3%) | $3.40 M(-2.9%) |
| Mar 1990 | - | $3.50 M(-2.8%) |
| Dec 1989 | - | $3.60 M(+12.5%) |
| Sept 1989 | - | $3.20 M |
| June 1989 | $3.00 M | - |
FAQ
- What is Bio-Techne annual total liabilities?
- What is the all time high annual total liabilities for Bio-Techne?
- What is Bio-Techne annual total liabilities year-on-year change?
- What is Bio-Techne quarterly total liabilities?
- What is the all time high quarterly total liabilities for Bio-Techne?
- What is Bio-Techne quarterly total liabilities year-on-year change?
What is Bio-Techne annual total liabilities?
The current annual total liabilities of TECH is $635.02 M
What is the all time high annual total liabilities for Bio-Techne?
Bio-Techne all-time high annual total liabilities is $718.82 M
What is Bio-Techne annual total liabilities year-on-year change?
Over the past year, TECH annual total liabilities has changed by -$37.16 M (-5.53%)
What is Bio-Techne quarterly total liabilities?
The current quarterly total liabilities of TECH is $597.37 M
What is the all time high quarterly total liabilities for Bio-Techne?
Bio-Techne all-time high quarterly total liabilities is $767.19 M
What is Bio-Techne quarterly total liabilities year-on-year change?
Over the past year, TECH quarterly total liabilities has changed by -$160.25 M (-21.15%)